Horizon Pharma (HZNP) Tops Q2 EPS by 12c

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of $0.62, $0.12 better than the analyst estimate of $0.50. Revenue for the quarter came in at $257.4 million versus the consensus estimate of $234.88 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
• Ladder Capital (LADR) Tops Q1 EPS by 4c